Bharat Bio's Telangana unit failed GMP test, led to Covaxin suspension: WHO https://ift.tt/FdrT5zB

It was non-compliance with good manufacturing practices (GMP) at Bharat Biotech's flagship vaccine manufacturing facility at Hyderabad's Genome Valley that led to the World Health Organisation (WHO) suspending Covaxin supply for UN procurement.

from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/DzAF9Mx
Share:

No comments:

Post a Comment

Search This Blog

Powered by Blogger.

Labels

Labels

Blog Archive

Recent Posts

Unordered List

  • Lorem ipsum dolor sit amet, consectetuer adipiscing elit.
  • Aliquam tincidunt mauris eu risus.
  • Vestibulum auctor dapibus neque.

Pages

Theme Support

Need our help to upload or customize this blogger template? Contact me with details about the theme customization you need.